Elementis PLC Trading Update

RNS Number : 0269U

Elementis PLC

21 January 2025

 

 

21 January 2025

 

 

 

Elementis plc

Trading Update

 

Results ahead of expectations, continued strategic progress.

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues its scheduled trading update for the three months and year ended 31 December 2024.

 

Elementis will publish its results for the financial year to 31 December 2024 on 6^th March 2025.

 

A strong performance, ahead of expectations

The Group has delivered a strong fourth quarter performance, with continued revenue growth and double-digit profit growth across Coatings and Personal Care, compared with Q4 2023.

 

As a result, adjusted operating profit for the financial year 2024 is expected to be in the range of $126-128 million, ahead of expectations¹, and significantly higher compared with the prior year (2023: $104 million).  

 

Adjusted operating margin above 17% for the 2024 financial year (2023: 14.6%) demonstrates good progress on the efficiency and growth programmes, introduced at the November 2023 Capital Markets Day.

 

Cash generation strengthens balance sheet

Strong cash generation supported further deleveraging, with net debt anticipated to be below $160 million (pre IFRS 16) at the end of the financial year 2024 (2023: $202 million). This represents a leverage ratio of approximately 1.0x net debt to EBITDA (pre IFRS 16), down from 1.5x at the start of the year.

 

Talc strategic review

The strategic review of Talc, announced on 1^st August, is progressing and a further update will be provided in due course.

 

 

Note: 1. Based on company compiled consensus: FY 2024 adjusted operating profit range of $121-125 million.

 

Enquiries

Investors:          Eva Hatfield, Elementis plc                                Tel: [phone]

Press:               Olivia Peters/Martin Robinson, Teneo                 Tel: [phone]

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

UPDEAXFEASPSEFA